This graphic from Siemens Healthcare Diagnostics presents the risk factors and troubling statistics on the disease worldwide.
Institutions that work with lab animals should establish a “culture of care” to make sure animals are treated with compassion.
Despite omics technologies being capable of generating thousands of biomarker candidates, so few actually make it to clinical use.
Behind a given tumor type, many pathogenic mechanisms may lurk. Uncover them with NGS and customize therapies accordingly.
The guiding principle is global information accessibility.
Learn more about this primarily cancer-driven research landscape.
Sequencing power for every scale.
Be sure to add firstname.lastname@example.org
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2014 Genetic Engineering & Biotechnology News All Rights Reserved